ZL-82

N/A

Report date: 2026/05/07 20:00:36
NME

Base Information

Drug NameZL-82
Drug Alias NameZL-82ZL82
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK3 inhibitors
TargetsTyrosine-protein kinase JAK3
Therapy Area/IndicationsVitiligoDermatitis, AtopicBehcet Syndrome +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesChengdu Zenitar Biomedical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesChengdu Zenitar Biomedical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsVitiligoDermatitis, AtopicBehcet Syndrome +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A